Latest filing published 17 May 2021 for Eloxx Pharmaceuticals, Inc., €2.7M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Rajesh B. Parekh: trading record in brief
Rajesh B. Parekh is a declared insider of Eloxx Pharmaceuticals, Inc. (board member), with filings sourced from SEC (Form 4). Over a trading history stretching from 1 April 2021 to 13 May 2021, the count stands at 4 filings.
Every open-market trade on record is a purchase: 2 purchases worth €2.8M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants.
The latest filing, published on 17 May 2021, reports an open-market purchase of €2.7M in Eloxx Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Rajesh B. Parekh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,381,890 shares@ US$1.3596.6% of flowCommon StockSEC:0001104659-21-067516:1Canonical exit: 11 Aug 2021 (T+90)
- 84,776 shares@ US$1.35100.0% of flowCommon StockSEC:0001104659-21-067516:0Canonical exit: 11 Aug 2021 (T+90)
- 87,031 sharesCommon StockSEC:0001415889-21-001896:0
- 2,445,239 sharesCommon StockSEC:0001415889-21-001896:1
4 of 4 declarations
